These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 9718318)

  • 1. Correlations of the basicity of His 57 with transition state analogue binding, substrate reactivity, and the strength of the low-barrier hydrogen bond in chymotrypsin.
    Lin J; Cassidy CS; Frey PA
    Biochemistry; 1998 Aug; 37(34):11940-8. PubMed ID: 9718318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new concept for the mechanism of action of chymotrypsin: the role of the low-barrier hydrogen bond.
    Cassidy CS; Lin J; Frey PA
    Biochemistry; 1997 Apr; 36(15):4576-84. PubMed ID: 9109667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A low-barrier hydrogen bond in subtilisin: 1H and 15N NMR studies with peptidyl trifluoromethyl ketones.
    Halkides CJ; Wu YQ; Murray CJ
    Biochemistry; 1996 Dec; 35(49):15941-8. PubMed ID: 8961961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The deuterium isotope effect on the NMR signal of the low-barrier hydrogen bond in a transition-state analog complex of chymotrypsin.
    Cassidy CS; Lin J; Frey PA
    Biochem Biophys Res Commun; 2000 Jul; 273(2):789-92. PubMed ID: 10873682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractionation factors and activation energies for exchange of the low barrier hydrogen bonding proton in peptidyl trifluoromethyl ketone complexes of chymotrypsin.
    Lin J; Westler WM; Cleland WW; Markley JL; Frey PA
    Proc Natl Acad Sci U S A; 1998 Dec; 95(25):14664-8. PubMed ID: 9843946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of low-barrier hydrogen bonding and oxyanion binding in transition state analogue complexes of chymotrypsin.
    Neidhart D; Wei Y; Cassidy C; Lin J; Cleland WW; Frey PA
    Biochemistry; 2001 Feb; 40(8):2439-47. PubMed ID: 11327865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The low barrier hydrogen bond (LBHB) proposal revisited: the case of the Asp... His pair in serine proteases.
    Schutz CN; Warshel A
    Proteins; 2004 May; 55(3):711-23. PubMed ID: 15103633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of the His57-Asp102 dyad of rat trypsin D189S in the zymogen, activated enzyme, and alpha1-proteinase inhibitor complexed forms.
    Kaslik G; Westler WM; Gráf L; Markley JL
    Arch Biochem Biophys; 1999 Feb; 362(2):254-64. PubMed ID: 9989934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-Oxalocrotonate tautomerase: pH dependence of catalysis and pKa values of active site residues.
    Stivers JT; Abeygunawardana C; Mildvan AS; Hajipour G; Whitman CP
    Biochemistry; 1996 Jan; 35(3):814-23. PubMed ID: 8547261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of chymotrypsin-trifluoromethyl ketone inhibitor complexes: comparison of slowly and rapidly equilibrating inhibitors.
    Brady K; Wei AZ; Ringe D; Abeles RH
    Biochemistry; 1990 Aug; 29(33):7600-7. PubMed ID: 2271520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of chymotrypsin by peptidyl trifluoromethyl ketones: determinants of slow-binding kinetics.
    Brady K; Abeles RH
    Biochemistry; 1990 Aug; 29(33):7608-17. PubMed ID: 2271521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 15N and 1H NMR spectroscopy of the catalytic histidine in chloromethyl ketone-inhibited complexes of serine proteases.
    Tsilikounas E; Rao T; Gutheil WG; Bachovchin WW
    Biochemistry; 1996 Feb; 35(7):2437-44. PubMed ID: 8652587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR studies of the role of hydrogen bonding in the mechanism of triosephosphate isomerase.
    Harris TK; Abeygunawardana C; Mildvan AS
    Biochemistry; 1997 Dec; 36(48):14661-75. PubMed ID: 9398185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 13C and 1H NMR studies of ionizations and hydrogen bonding in chymotrypsin-glyoxal inhibitor complexes.
    Spink E; Cosgrove S; Rogers L; Hewage C; Malthouse JP
    J Biol Chem; 2007 Mar; 282(11):7852-61. PubMed ID: 17213185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. His-357 of beta-galactosidase (Escherichia coli) interacts with the C3 hydroxyl in the transition state and helps to mediate catalysis.
    Roth NJ; Rob B; Huber RE
    Biochemistry; 1998 Jul; 37(28):10099-107. PubMed ID: 9665715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of the reaction catalyzed by mandelate racemase: structure and mechanistic properties of the D270N mutant.
    Schafer SL; Barrett WC; Kallarakal AT; Mitra B; Kozarich JW; Gerlt JA; Clifton JG; Petsko GA; Kenyon GL
    Biochemistry; 1996 May; 35(18):5662-9. PubMed ID: 8639525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chymotrypsin inhibitory conformation of dipeptides constructed by side chain-side chain hydrophobic interactions.
    Sakamoto H; Shimohigashi Y; Maeda I; Nose T; Nakashima K; Nakamura I; Ogawa T; Kawano K; Ohno M
    J Mol Recognit; 1993 Jun; 6(2):95-100. PubMed ID: 8305253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subangstrom crystallography reveals that short ionic hydrogen bonds, and not a His-Asp low-barrier hydrogen bond, stabilize the transition state in serine protease catalysis.
    Fuhrmann CN; Daugherty MD; Agard DA
    J Am Chem Soc; 2006 Jul; 128(28):9086-102. PubMed ID: 16834383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-barrier hydrogen bonding in molecular complexes analogous to histidine and aspartate in the catalytic triad of serine proteases.
    Tobin JB; Whitt SA; Cassidy CS; Frey PA
    Biochemistry; 1995 May; 34(21):6919-24. PubMed ID: 7766600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH dependence of the reaction catalyzed by yeast Mg-enolase.
    Vinarov DA; Nowak T
    Biochemistry; 1998 Oct; 37(43):15238-46. PubMed ID: 9790688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.